Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells

Fatemeh Atyabi, Fatemeh Talaie

Open source

DOI
10.2147/ijn.s22731
Published
2011-09
Container
International Journal of Nanomedicine
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ijn.s22731,
  title = {Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells},
  author = {Fatemeh Atyabi and Fatemeh Talaie},
  year = {2011},
  journal = {International Journal of Nanomedicine},
  doi = {10.2147/ijn.s22731},
  url = {https://doi.org/10.2147/ijn.s22731}
}

RIS

TY  - JOUR
TI  - Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells
AU  - Fatemeh Atyabi
AU  - Fatemeh Talaie
PY  - 2011
JO  - International Journal of Nanomedicine
DO  - 10.2147/ijn.s22731
UR  - https://doi.org/10.2147/ijn.s22731
ER  - 

APA

Atyabi, F., & Talaie, F. (2011). Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s22731

Source records